REIMAGING EEG STUDIES. ANYTIME. ANYWHERE.

Clinician Efficiency

NeuroCap™ and NeuroEEG™ were designed to make testing more efficient allowing clinicians time to focus on test readings rather than focus on the labor-intensive application process of current electrode placement technology. Ease of prep and rapid testing enables clinicians to complete more EEG tests throughout the day, facilitating their ability to diagnose more patients with ease and efficiency.

LEARN MORE

RAPID EEG TESTING. ANYTIME. ANYWHERE.

Patient Accessibility

Utilizing our single-use NeuroCap™ and portable NeuroEEG™ enables clinicians to conduct an EEG test anywhere. Whether visiting a hospital, emergency room, ICU, specialty clinic, ambulance, or even on the athletic field our products are designed to be used anywhere. Ask for Brain Scientific by name to receive rapid EEG testing.

LEARN MORE

RESHAPING EEG STUDIES. ANYTIME. ANYWHERE.

Diagnose Confidently

Brain Scientific’s Neurology EEG Ecosystem provides clinicians and patients confidence in gaining rapid access to accurate EEG test results. Beginning with the ease of use and application of NeuroCap™ when diagnosing neurological conditions such as epilepsy and numerous seizure disorders, brain tumors, infections, injury, dementia, stroke to attention disorders.

LEARN MORE

RAPID EEG TESTING. ANYTIME. ANYWHERE.

Pre-gelled EEG cap, Fast Prep and Testing, Simple to Use

At Brain Scientific, our mission is to provide clinicians with the right solution at the right time; wherever, whenever a diagnosis is needed.

Our priority is to enable rapid, convenient, and accurate neurology solutions.

LEARN MORE

Accessible | Efficient | Accurate

Conventional EEG practices in Neurology have been static for years compounding frustrations for clinicians and patients across the board.

 

Until now. 

 

Our innovative NeuroCap™, NeuroEEG™ and  NeuroHub™ (coming in 2023) lead the way in advancements for prepping, testing, and interpreting EEG studies anytime, anywhere.

 

NeuroCap

NeuroCap™

Disposable EEG headset with 22 pre-gelled electrodes, and 19 active channels in accordance with the international 10-20 system

 

NeuroEEG

NeuroEEG™

Portable, 21-channel, wireless amplifier coming in 2023 to use in conjunction with our NeuroCap™

 

NeuroHub

 

NeuroHub™

State-of-art Neurology SaaS platform coming 2023 by the Brain Scientific team to collect and aggregate data from current and future BRSF devices like the NeuroCap™, NeuroEEG™

NeuroCap™+ NeuroEEG™+ NeuroHub™

The team at Brain Scientific has made it our mission to build a complete Neurology EEG EcoSystem, offering two distinct devices to streamline your EEG prep, testing, and diagnosis. NeuroCap™ our disposable headset with 22 pre-gelled electrodes follows the international 10–20 system, and our hand-held, wireless, 21-channel NeuroEEG™ amplifier provides confidence to clinicians and patients when testing to detect abnormalities in brain waves, or in the electrical activity of the brain to diagnose neurological disorders. 

 

NeuroCap™ provides numerous benefits to clinicians and patients. Any healthcare worker can prep and apply NeuroCap™ in just 5-minutes, no longer requiring you to wait for your tech-on-call, all the while shortening the time to reading test results, evaluating, and diagnosing your patient. NeuroCap™ is compatible with 3rd party amplifiers when using our universal cable with the touch-proof DIN connectors.  

 

As our healthcare providers focus on enabling and utilizing telehealth to diagnose and treat patients, NeuroCap™ enables tele-neurology allowing clinicians to make rapid decisions remotely and bridging the gap in access to neurological care. Using NeuroCap™ can accelerate the time to diagnosis, eliminate the need for your patients to travel distances to testing site facilities, and provide a timely and accurate diagnosis in an efficient manner. 

 

NeuroEEG™ is our 21-channel amplifier that provides clinicians the same quality as traditional EEG equipment. The portability and wireless connectivity offer you the ability to test anywhere in your hospital, office, remote setting, or ambulance to quickly serve your patients. 

 

NeuroHub™ is a state-of-art Neurology SaaS platform used to collect and aggregate data from current and future BRSF devices like the NeuroCap™, NeuroEEG™, and external sources such as research and medical data banks, 3rd-party devices, and clinical-use applications. NeuroHub™ will allow comprehensive monitoring and facilitate collaborative diagnosis, analysis, research, treatment, and prevention by employing sophisticated Artificial Intelligence (AI) and machine learning (ML) algorithms utilizing historical and current patient, device, and platform data.

Learn More
BRSF_DrGiantis_Testimonial_Homepage.png

“This is a great solution for the emergency room setting. It’s a great solution for telemedicine. It’s an excellent solution too for hospitals that don’t have 24/7 in-house EEG support. Even a patient that is already admitted to the hospital may suddenly go into a seizure or have an unexplained mental status change. At 2 in the morning, we need to know if that patient is going into a seizure. This is a product that even if you have EEG technicians in-house they may not arrive until 6 a.m. So from 2 a.m. until 6 a.m., this device gives you the ability to determine if the patient is in status epilepticus so you can begin treatment and not lose time. A product like this substantially reduces the time and skill set needed to run an EEG. They can record the data and get their answer very quickly.”

Dr. John Gaitanis, Chief of Pediatric Neurology at Tufts Medical Center 
BRSF_DrGiantis_Testimonial_Homepage.png

LATEST NEWS

BRSF_Brain_Binary_NewsThumbnail

Brain Scientific Announces Private Placement of $5.6 Million of Senior Secured Convertible Debentures and Warrants, Converts Approximately $12.9 Million of Existing Debt into Equity

June 15, 2022

Brain Scientific (OTCQB: BRSF) (the “Company”), a medical technology company with multiple patents and FDA-cleared products, today announces that it has entered into definitive agreements with certain institutional and accredited investors for the sale of senior secured convertible debentures and warrants to purchase shares of the Company’s common stock, resulting in total gross proceeds of approximately $5.1 million before deducting the placement agent’s fees and other offering expenses.

Modern,Medical,Equipment,In,A,Patient,Room,In,A,Hospital

Expedited EEG testing for Epilepsy

June 7, 2022

According to the World Health Organization, each year five-million people worldwide are diagnosed with Epilepsy, a neurological disorder that affects the brain. While there is no cure for epilepsy, early detection and treatment of seizures is critical for patient care. The WHO estimates up to 70% of people with epilepsy could live seizure-free if properly…

Football,Tackle

Bring EEG Testing to the Sports Field to Assess for Concussions

June 1, 2022

The CDC estimates, 1.6-3.8 m sports and recreation related concussions occur each year in the U.S. Generally, concussions are not life-threatening through multiple factors including age, severity of concussion and past concussion history do effect recovery. Subsequent concussions, prior to full injury recovery may lead to increased severity in brain injury.    A study released as part…

Young male doctor showing medical test results on tablet to young woman with little daughter

How can you ensure comfort and compliance when performing an EEG for a pediatric patient?

April 27, 2022

Acquiring an accurate EEG for pediatric patients has historically been limited by several obstacles, including uncontrollable movement during testing, which can lead to inaccurate results.    Often patients with behavioral issues, sensory challenges, or autism find it difficult to sit still while the electrodes are applied, especially those with acute anxiety issues who may find…

Your questions are important to us.

Have a question? Contact Brain Scientific and a member of our team will reach back out to you.

Get in Touch